Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

Rivaroxaban Flops for Prevention in Advanced CKD

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting prevention seen in other high-risk populations.

Advance Directives May Reduce Unnecessary End-of-Life Care

Older adults close to death often receive unnecessary end-of-life medical treatments in hospitals.

Obesity Stigma: Is Art History the Fix?

Learning through art history that obesity once denoted prosperity, strength, and beauty, may help healthcare providers treat patients with more compassion, a researcher proposes.

Retatrutide Data Show Dramatic Weight Loss, Other Benefits

Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

FDA Neurology Roundup: May 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Solutions Emerging for Post-GLP-1 Weight Regain

As real-world studies show high rates of GLP-1 discontinuation and rapid weight regain, new interventions may help patients maintain weight loss.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting prevention seen in other high-risk populations.

Older adults close to death often receive unnecessary end-of-life medical treatments in hospitals.

Learning through art history that obesity once denoted prosperity, strength, and beauty, may help healthcare providers treat patients with more compassion, a researcher proposes.

Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

As real-world studies show high rates of GLP-1 discontinuation and rapid weight regain, new interventions may help patients maintain weight loss.

News All Time

Planetary Health Diet May Lower Obesity Risk at Menopause

The planetary health and low-insulinemic diets — rich in plants and whole grains and low in red and processed meats and fried foods — can aid weight management during menopause, a recent study shows.

Prasugrel Outshines Rival Drugs After Invasive Coronary Care

Among commonly used antiplatelet agents, prasugrel offers the most optimal balance between efficacy and safety after invasive management of patients with coronary syndrome, a meta-analysis finds.

Food Additives: Is New Evidence Raising Safety Questions?

Large cohort studies link several food colorings and preservatives to higher risks for diabetes, cancer, hypertension, and cardiovascular disease.

FDA-Cleared ACORYS: Catheter-Free Cardiac Mapping

Noninvasive mapping with hundreds of body surface electrodes transforms the inverse ECG problem, letting AI and models infer intracardiac activation without catheter insertion.

Proteinuria in Preeclampsia Tied to Hypertension & CKD Risks

Among women with preeclampsia, high levels of urinary protein excretion are associated with increased long-term risks for hypertension and chronic kidney disease.

Home Cardiac Rehab Data Signal Wider Access Gains

Home-based digital cardiac rehab platforms are reaching women, ethnic minorities, and deprived communities missed by conventional services, new data show.

Cycling Linked to Higher Arrhythmia Risk in Middle-Aged Men

More hours of lifetime endurance exercise are linked to increased odds of reporting atrial fibrillation or atrial flutter in middle aged men, and cycling shows an independent association.

Tackling Barriers to Lipid Management in Primary Care

Experts at the Primary Care Show identified the key barriers to lipid management — and what clinicians can do about them.

Pemvidutide Shows Liver and Cardiovascular Benefits in MASH

Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase 2b data show.

Certain BP Drugs and Combos Better Tolerated Than Others

BP-lowering regimens with angiotensin receptor blockers are linked to a lower risk for discontinuation due to adverse events, while other drugs and combinations are linked to higher risk.

Daptomycin May Match Vancomycin in Resistant Endocarditis

Daptomycin offers similar effectiveness to vancomycin in treating left-sided infective endocarditis caused by methicillin-resistant staphylococci and is associated with a better safety profile.

AI Spots Undertreated Heart Failure Risk Early

An AI tool applied to NHS health records identified stable-appearing heart failure patients who were undertreated and at high risk before hospital admission.

Metabolic Changes Prompt Alcohol Cravings in AUD, Obesity

People with comorbid alcohol use disorder and obesity may represent a distinct clinical subgroup, with glucose dysregulation driving alcohol craving and the risk for relapse.

Treat the Overlap Between Long COVID and Chronic Fatigue

As more patients seek help for myalgic encephalomyelitis/chronic fatigue syndrome and similar symptoms for long COVID, primary care clinicians play a bigger role in treatment.

Does Obesity Drive Related Conditions in Older Adults?

Many health conditions related to obesity are common in older adults, but some are more attributable to obesity than others.

Higher Abdominal Fat Linked to Faster Biological Aging

Higher abdominal fat is associated with accelerated biological aging across multiple measures, and metabolic aging explains much of the increased risks for heart disease and death.